Comment on article in Daily Mail Good Health

25th January 2011

Following a recent article in the Daily Mail the ACSM, Association of Commercial Specials Manufacturers, is keen to reassure patients of the need for specials or unlicensed medicines.   The article raised questions about the necessity of providing specially prepared liquid forms of common medicines for some patients. 

Although the ACSM cannot comment on the details of the drug preparation in the article, in general, unlicensed medicines are prescribed by a doctor to meet a patient’s specific clinical need, for example, allergy to drug excipients or inability to swallow. 

In these instances a doctor may decide to prescribe a special if there is no licensed alternative available to give to the patient.  Splitting and crushing tablets is not a satisfactory alternative as it does not always result in the patient receiving the correct formulation leading to a patient getting a much higher or much lower dose than is prescribed.

Anyone who has concerns about the need for their Special prescription is encouraged to talk to their doctor or pharmacists for advice and guidance but should not attempt to formulate their own medicines.



FOLLOWING CONSULTATION WITH DH AND PSNC, THE ACSM LOOKS FORWARD TO SPECIALS PRICING SYSTEM

The ACSM, whose members produce a large proportion of the Specials manufactured in the UK, has been consulting with the Department of Health (DH) about a method of controlling the cost of Specials that doesn't compromise the supply to vulnerable patients. As outlined in the article below (Chemist and Druggist), the ACSM looks forward to a solution this year.

The current market structure makes it possible to re-sell Specials through a distribution chain over which neither the original manufacturer nor the NHS has control. In this way, the reimbursement price paid is sometimes decided further down the distribution chain and can be significantly different from the original ex-factory prices.

The ACSM, Association of Commercial Specials Manufacturers, believes resolution will lead to greater transparency within the sector and help eliminate the potential for excessive price inflation within the distribution chain which has affected the industry’s reputation. ACSM members are concerned that negative media attention could threaten the supply of to vulnerable patients in the long term if confidence is not restored in the sector.



http://www.chemistanddruggist.co.uk/c/portal/layout?p_l_id=259751&CMPI_SHARED_articleId=4555671&CMPI_SHARED_ImageArticleId=4555671&CMPI_SHARED_articleIdRelated=4555671&CMPI_SHARED_ToolsArticleId=4555671&CMPI_SHARED_CommentArticleId=4555671&articleTitle=Specials%20drug%20tariff%20imminent,%20says%20PSNC&cid=latest_headline_2&sp_rid=NjU3NzI3Mjk5NQS2&sp_mid=36234096


Comments

  1. Purador5 October 2011 at 12:05

    I just couldn’t leave your website before telling you that we really enjoyed the quality information you offer to your visitors… Will be back often to check up on new posts. Argan Oil

    ReplyDelete

Post a Comment

Popular posts from this blog

The Specials Tariff is important to ensure confidence and best practice within the sector

In response to an article in The Daily Telegraph June 22 nd , the APSM, Association of Pharmaceutical Specials Manufacturers, has spoken out in support of the Specials Tariff, a system that was introduced by the DOH to create a more transparent process for reimbursing specials, linking the cost of reimbursement to the cost of the product, while providing value for money for the NHS.  Since the introduction of the Specials Tariff in November 2011, the average cost per item has fallen by 25% (from £180 to £135).   The Specials Tariff was set using a system similar to that used for the calculation of the price of category M generics.  Under a memorandum of understanding (MOU), licensed specials manufacturers provided sales information to the DOH, which has been used to set a reimbursement price that includes margin.     These prices take into the account the high quality manufacturing processes that must be adhered to by companies wishing to supply products listed on the Specials
Read more

Specials record another year of delivering increased value to the NHS

The Specials Market in primary care was just over £ 80.5 million for the 12 month period Oct 15 - Sep 16.  Although the market continues to decline year-on-year, it is now stabilising following a period of readjustment in the wake of the Specials Tariff in November 2011.  During this time the mean cost per item has reduced from £180 per item before the tariff in Nov 2011, to an average £116 for the same 12 month period to Sep 2016. Whilst this represents value for money to the NHS, at the same time the high standards of quality involved in Specials manufacture have needed to be maintained.  According to the Association of Pharmaceutical Specials Manufacturers, APSM, members report continued investment in infrastructure and quality processes to meet the increasing regulatory demands required by the sector. To reflect the increased complexity of the market, l ast year (2016), the Association of Pharmaceutical Specials Manufacturers, APSM, decided to broaden its membership criter
Read more

APSM expands membership to reflect changing role of specials industry

The Association of Pharmaceutical Specials Manufacturers, APSM, has broadened its membership criteria to include importers as well as virtual Specials manufacturing organisations who own the rights to, and act as the first supplier of, a Specials medicine in the UK. Originally founded to represent the interests of holders of a Specials Manufacturing Licence, the APSM has an important role liaising with the DH and key policy makers as well as inputting into decisions around new legislation and Specials guidance. The decision to broaden membership to the wider supply chain reflects the changing shape of the Specials market, particularly over the last 5 years following the introduction of the Specials Tariff alongside a developing regulatory framework and professional guidance around Specials.  Influencing and responding to issues in this changing market has also become a more important role for the APSM. APSM Chair, Sharon Griffiths, said, “The decisions and actions we take now h
Read more